stockrowAgios Pharmaceuticals, Inc. (AGIO) vs Novavax, Inc. (NVAX)
- Agios Pharmaceuticals, Inc. AGIO 29.41 +4.03%
- Novavax, Inc. NVAX 10.78 +10.22%
Agios Pharmaceuticals, Inc. and Novavax, Inc. are both Biotechnology companies. Agios Pharmaceuticals, Inc. and Novavax, Inc. are of similar size ($1.7B and $1.6B). Agios Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 214.4% against −61.3%. Novavax, Inc. has the higher net margin (−18.6% vs −264.8%) and the higher return on invested capital (0.00% vs −75.0%). Across the 16 metrics below, Novavax, Inc. leads on 13 and Agios Pharmaceuticals, Inc. on 3.
Valuation
Profitability
| Metric | AGIO | NVAX | Biotechnology median |
|---|---|---|---|
| Gross margin | 93.81% | 78.01% | 68.51% |
| Operating margin | (297.72%) | (21.23%) | 0.00% |
| Net margin | (264.76%) | (18.64%) | 0.00% |
| Free cash flow margin | (238.54%) | (58.05%) | 0.00% |
| Return on equity | (32.95%) | 41.08% | (51.96%) |
| Return on assets | (30.44%) | (7.42%) | (46.06%) |
| Return on invested capital | (75.02%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack